Liminal BioSciences Inc. PFSCF

716 Reads?!? Someone liked what this company is doing...

[Biofinder]

There are a lot of positives this company is doing, and some that have been questionable like the overly optimistic dates that PL pumped for FDA approval of Ryplazim that most of us relied upon for timelines, mistake noted.

But no one can question the science behind the drugs, and for that I say “thank you PLI”, because those who can afford to wait will be richly rewarded...

..and for those who can’t wait, well, those are the posters who only post negativity and criticism of PL and other posters -> they contribute nothing to the Prometic conversation, and that’s why posters like HT, GunnerG, and many others are pushing 200 ignores; the negative posters are ignored for a reason.

May 10, 2018 - 11:44 PM 716 Reads 
Post# 28016174

 

 

 

Back from holiday, just listen to the AGM... my take:

 

China deal killed because 4050 more valuable for WW pending deal.

 

4050 deal has been agreed in principle, details now being worked out.

(summer)

 

Ryplazim works in all patients 100% of the time, no exceptions!

(and with zero adverse side effects)

 

Pediatric voucher is in the bag, but timeline is uncertain.

 

4050 REVERSES FIBROSIS in 5 organs/systems - unbelievable!

 

4050 works in Alstrom patients - THE most difficult of all fibrosis patients.

 

52+ weeks of proven clinical data that 4050 works in Alstrom patients.

(efficacy maintained! and improved! safety is a non issue/very safe)

 

4050 clinical data -> the longer patients take 4050 the better the results.

 

4050 has clinically proven activity, and is safe and well tolerated.

 

Increasing 4050 dosage to 1200mg in IPF phase 3 trial (significant!)

 

4050 and Ryplazim = full spectrum of IPF treatment.

(Prometic will own the IPF market by 2021)

 

PBI-4050 = BLOCKBUSTER ($50+ Billion USD WW market potential)

Ryplazim = BLOCKBUSTER ($8+ Billion USD WW market potential)

 

I’ll let the morons on this board worry about money (and post accordingly)

This investor is NOT worried about financing or dilution 

I’ve seen this movie before...

This drug pipeline (4050 and Ryplazim) is so revolutionary, and 

The market potential is so vast ($58+ Billion), that

Financing and dilution means nothing.

 

PPPS will change the industry.

 

My Only Concern: the timing of reverse split for NASDAQ listing...

 

Everything appears to remain on track for 2020 imvho.
 

Read more at https://www.stockhouse.com/companies/bullboard#wzqO0XgTIFHC7oSE.99